91Ö±²¥

Overview

Many routine health care appointments, which were once undertaken face-to-face, were undertaken remotely (i.e., over the telephone or via video call) due to the social distancing rules put in place during the COVID-19 pandemic. Face-to-face appointments have, in the past, been used to recruit patients to clinical trials, or collect their follow-up data during a clinical trial. Therefore, many clinical trials had to adapt their procedures in order to carry on during the pandemic. 

The need for trials to attempt to reduce in-person contact presents a rare opportunity to study novel adaptations in trials. It seems likely that post-pandemic healthcare will change and remote contact may become the new normal - clinical trials will need to adapt. Therefore, guidance is needed in order to assist CTUs and to inform the efficient design of trials post pandemic. 

The aim of this project, which has been funded by the NIHR CTU Support Funding stream, was to find out how clinical trials have adapted to the pandemic, specifically focussing on the recruitment, intervention delivery and follow-up of trial participants. The overall aim was to identify adaptations that have the potential to improve the efficiency of future clinical trials. The project produced guidance documents to assist CTUs in improving the efficiency of clinical trials – these can be downloaded below.

Guidance documents

The guidance documents, detailing the methods, results, and conclusions of the study, can be downloaded below. There are two versions of the guidance documents:

• Summary guidance document 
• Detailed guidance document

Contact

If you have any questions, please contact the project lead:

Robin Chatters – r.chatters@sheffield.ac.uk, 01142222969

Project team

• Robin Chatters - 91Ö±²¥ Clinical Trials Research Unit, 91Ö±²¥
• Professor Cindy Cooper - 91Ö±²¥ Clinical Trials Research Unit, 91Ö±²¥
• Professor Chris Burton – School of Health and Related Research, 91Ö±²¥
• Professor Alicia O’Caithain - School of Health and Related Research, 91Ö±²¥
• Professor Athene Lane - Bristol Trials Centre, University of Bristol
• Caroline Murphy - King’s Clinical Trial Unit, King’s College London
• Angela Cape - King’s Clinical Trial Unit, King’s College London
• Professor David Torgerson - York Trials Unit, The University of York
• Professor Jane Nixon - Leeds Clinical Trials Unit, The University of Leeds

Downloads

• Protocol
• Summary guidance document 
• Detailed guidance document
• Table 1: Description of adaptations included in work package 2
• Table 2: Efficiency of the adaptations, challenges and benefits, and considerations
• Table 3: Details of adaptations that were deemed to have an unknown effect on trial efficiency